Navigation Links
Generex Touts Pipeline Potential of Antigen Express Subsidiary
Date:2/7/2013

platform.  This technology enhances delivery of key target proteins like HER2 for cancer to a critical immune recognition site enhancing immune recognition. The Company has also developed compounds designed for important non-HER2 cancer associated protein targets using the Ii-Key technology platform. These include the melanoma-associated gp100 target, as well as cervical and head-and-neck cancers associated with Human Papilloma Virus (HPV). These compounds have shown significant activity in animal models that has been described in peer-reviewed publications.

In addition to cancer protein targets, the Company has clinically tested Ii-Key-based proteins designed to protect against the potentially pandemic influenza strains H5N1 (avian flu) and H1N1 (swine flu). The advantage here is that the Antigen vaccine technology is entirely synthetic, making it simple to manufacture. In the event of a potentially pandemic influenza virus, there is clearly a need for this type of flexible vaccine technology that can be brought into production rapidly.

The distinguishing feature of Antigen Express technology (Ii-Key) is the ability to activate critical components of the immune system (CD4+ T helper cells) in a robust and specific manner. Currently this is a unique technology platform that directs proteins to a critical immune component to be able to create specific immune stimulation. This Ii-Key technology is proprietary to Antigen Express. Consequently, the Company is in a good position to license the technology for combination with multiple different target proteins to create novel vaccine applications that may be of interest to other researchers and companies.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavit
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
2. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
3. Generex Augments Antigen Express Scientific Advisory Board
4. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
5. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
6. Generex Announces Results of Annual Stockholders Meeting
7. Generex Addresses Recent Trading Volume in Shares of its Common Stock
8. Generex Announces Details of Investor Conference Call
9. Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
10. Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
11. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014  Aethlon Medical, Inc. (OTCQB:AEMD), announced today that ... approximately $3.3 million at a price of $0.30 per ... focused investor. Each unit consists of one common share ... warrant. Each whole warrant entitles the holder to acquire ... a period of five years from closing.  ...
(Date:11/26/2014)...   Regulus Therapeutics Inc . (NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... of Regulus, will present a company overview at the ... the New York Palace Hotel on Wednesday, December 3, ... webcast at the time of the presentation and can ...
(Date:11/26/2014)... , Nov. 26, 2014  BioScrip ® , Inc. (NASDAQ: ... President and Chief Executive Officer, will present at the Bank of ... , , , Date: , , , Wednesday, December 3, ... p.m. EST , , , , Location: , , , ... About BioScrip, Inc. BioScrip, Inc. is ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3
(Date:11/27/2014)... (PRWEB) November 27, 2014 This ... on Global Insulin industry. For an overview analysis, ... classification, application, industry chain structure, industry overview, policy ... global Insulin industry covers information on policy, ... product cost structure and much more. ...
(Date:11/27/2014)... GA (PRWEB) November 27, 2014 "The uglier, ... whole month of December is full of laughter as we ... Wilson won by making a sweater from scratch. " It ... Christmas tree, and if that weren't ridiculous enough, the Christmas ... top. , For those interested in participating this year, ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 VeloReality Inc. ... six new Real Life Videos (RLVs) of world-famous velo courses ... Trainer, as well as other popular indoor velo trainers. Two ... available worldwide before the end of November -- in ... the total number of rides in the VeloReality collection to ...
(Date:11/26/2014)... 2014 Healthpointe is proud to provide ... , and it will be led by a renowned ... field of Occupational Medicine and utilizes the latest medical ... delivers quality care for employers and their employees, and ... , As an Occupational Medicine physician, Dr. ...
(Date:11/26/2014)... Day is traditionally the day following Christmas Day, when ... "Christmas box", from their bosses or employers. (Source from ... Day, some people may worry about the boxing day ... it has recently announced its “ Tbdress Boxing Day ... customers. Then people can buy cheap pants, dresses, shoes ...
Breaking Medicine News(10 mins):Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 3Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 2Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 3Health News:Tbdress.com: Best Boxing Day Sales For Ladies Worldwide 2
... new robotic surgery technique appears promising for the removal ... report in the December issue of Archives of OtolaryngologyHead ... Typically, surgeons trying to remove tonsils of patients with ... area, according to background information in the article. If ...
... Erline Perkins McGriff Professor and dean of the College of ... College board of,trustees., A 1976 graduate of Skidmore, she ... holds fellow status in the New York Academy of Medicine.,Fulmer ... Gerontological,Society of America, and also the first nurse to be ...
... New Series "Celebrity Rehab with Dr. ... ..., Maybe Baby" and "Scott Baio is 46 ... and Pregnant" Kick Off The New ... ... 2008 with a full,slate of new premieres and returning series. For the first time VH1 ...
... dietician, certified personal trainer, marathoner, and wellness enthusiast will design individualized ... better, longer, healthier and younger ... ... be, better nutrition for active,lifestyles available exclusively at Target stores, announces ...
... 17 Diagnostic Health Corporation,(DHC) today announced that ... its home office operations to 22 Inverness Center ... imaging company created,by HealthSouth,s sale of its diagnostic ... most of DHC,s 1,000 employees work in its ...
... - Aspreva Pharmaceuticals,Corporation (NASDAQ: ASPV ; TSX: ... approved the proposed acquisition of,Aspreva by Galenica Group ... price of US$26.00 per share in cash. At ... transaction was approved,by over 99% of the votes ...
Cached Medicine News:Health News:Robotic device appears useful for surgical removal of cancer involving the tonsils 2Health News:Terry Thomas Fulmer, Dean of NYU's College of Nursing, Elected to Skidmore College Board 2Health News:VH1 Set to Continue Its Record-Breaking Pace Into 2008 with Brand New Premieres and Returning Series 2Health News:VH1 Set to Continue Its Record-Breaking Pace Into 2008 with Brand New Premieres and Returning Series 3Health News:VH1 Set to Continue Its Record-Breaking Pace Into 2008 with Brand New Premieres and Returning Series 4Health News:be(R) is Making Health Simple With Complimentary, Expert Online Diet, Nutrition and Exercise Advice 2Health News:Diagnostic Health Corporation Announces New Home Office Location 2Health News:Aspreva obtains shareholder approval for acquisition by Galenica 2Health News:Aspreva obtains shareholder approval for acquisition by Galenica 3Health News:Aspreva obtains shareholder approval for acquisition by Galenica 4
Designed for OSA patients who have difficulty with conventional CPAP therapy, the ResMed SULLIVAN Comfort system is a solution for those who need an alternative to CPAP....
... The BiPAP Pro with Bi-Flex bi-level system, ... that the BiPAP Pro takes to change ... Digital Auto-Trak Sensitivity™ which automatically triggers the ... pressures based on the patients breathing rhythm. ...
... Provides an approach to ... With a pressure range to ... you to treat patients with ... also features integrated humidification and ...
... Method for the Separation and Measurement ... and Subfractions, ,The Lipoprint System is ... cholesterol components which are not routinely ... test provides detailed results within the ...
Medicine Products: